Clinical trial
PET Imaging to Determine the Role of PET in the Assessment of Regional Disease…
NCT00201942 · Ontario Clinical Oncology Group (OCOG), Other · Completed
Key facts
| NCT number | NCT00201942 |
|---|---|
| Title | PET Imaging to Determine the Role of PET in the Assessment of Regional Disease in Breast Cancer (PET PREDICT Trial) |
| Official title | A Prospective Study to Determine the Role of 2-[18F]Fluoro-2-Deoxy-D-Glucose (FDG)Positron Emission Tomography (PET)in the Assessment of Regional Nodal Spread of Disease in Breast Cancer Patients |
| Lead sponsor | Ontario Clinical Oncology Group (OCOG), Other |
| Collaborators | Ontario Ministry of Health and Long Term Care |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Procedure |
| Interventions | PET scan |
| Enrollment | 336 |
| Start date | Feb 1, 2005 |
| Completion | May 1, 2007 |
| First posted | Sep 20, 2005 |
| Last update posted | Oct 18, 2007 |
| Countries | Canada |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: